These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 2445926

  • 1. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin.
    Satoh M, Inagawa H, Shimada Y, Soma G, Oshima H, Mizuno D.
    J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926
    [Abstract] [Full Text] [Related]

  • 2. Priming effect of interferons and interleukin 2 on endogenous production of tumor necrosis factor in mice.
    Satoh M, Shimada Y, Inagawa H, Minagawa H, Kajikawa T, Oshima H, Abe S, Yamazaki M, Mizuno D.
    Jpn J Cancer Res; 1986 Apr; 77(4):342-4. PubMed ID: 2422147
    [Abstract] [Full Text] [Related]

  • 3. Role of in vivo scavenger function of macrophages in priming for endogenous production of tumor necrosis factor.
    Satoh M, Oshima H, Abe S, Yamazaki M, Mizuno D.
    J Biol Response Mod; 1987 Oct; 6(5):499-511. PubMed ID: 3681345
    [Abstract] [Full Text] [Related]

  • 4. Endogenous production of TNF in mice with immune complex as a primer.
    Satoh M, Inagawa H, Minagawa H, Kajikawa T, Oshima H, Abe S, Yamazaki M, Mizuno D.
    J Biol Response Mod; 1986 Apr; 5(2):140-7. PubMed ID: 3734841
    [Abstract] [Full Text] [Related]

  • 5. Human cytokines, tumor necrosis factor, and interferons: gene cloning, animal studies, and clinical trials.
    Bollon AP, Berent SL, Torczynski RM, Hill NO, Lemeshev Y, Hill JM, Jia FL, Joher A, Pichyangkul S, Khan A.
    J Cell Biochem; 1988 Apr; 36(4):353-67. PubMed ID: 2454238
    [Abstract] [Full Text] [Related]

  • 6. Production of tumor necrosis factor (TNF) by monocytes from cancer patients and healthy subjects induced by OK-432 in vitro, and its augmentation by human interferon gamma.
    Sekimoto M, Kokunai I, Shimano T, Kobayashi T, Takeda T, Haruna N, Yamamoto A, Mori T.
    J Clin Lab Immunol; 1988 Nov; 27(3):115-20. PubMed ID: 3150012
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Initial characterization of a lymphokine pathway for the immunologic induction of tumor necrosis factor-alpha release from human peripheral blood mononuclear cells.
    Kornbluth RS, Gregory SA, Edgington TS.
    J Immunol; 1988 Sep 15; 141(6):2006-15. PubMed ID: 3139748
    [Abstract] [Full Text] [Related]

  • 15. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)].
    Saito M, Yamaguchi T, Aonuma E, Noda T, Edina T, Ishida N.
    Gan To Kagaku Ryoho; 1982 Nov 15; 9(11):2031-7. PubMed ID: 6820888
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation.
    Mori H, Itoh N, Tamaya T.
    Immunopharmacol Immunotoxicol; 1989 Nov 15; 11(1):33-53. PubMed ID: 2503555
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nitric oxide-independent killing of Francisella tularensis by IFN-gamma-stimulated murine alveolar macrophages.
    Polsinelli T, Meltzer MS, Fortier AH.
    J Immunol; 1994 Aug 01; 153(3):1238-45. PubMed ID: 8027551
    [Abstract] [Full Text] [Related]

  • 19. [Definition of tumor-necrosis factor and its production mechanism].
    Urushizaki I, Niitsu Y, Watanabe N.
    Gan To Kagaku Ryoho; 1984 Jul 01; 11(7):1356-68. PubMed ID: 6378100
    [Abstract] [Full Text] [Related]

  • 20. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12.
    Shnyra A, Brewington R, Alipio A, Amura C, Morrison DC.
    J Immunol; 1998 Apr 15; 160(8):3729-36. PubMed ID: 9558074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.